Ignite acquires Ignite Proteomics
The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.
Company lists
Research tools, therapeutics, genomics, medical devices, startups and more: the companies building life sciences in Colorado, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 497 life sciences companies in Colorado, last 24 months: 32 funding rounds · 29 M&A deals · 12 Contracts. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.
Servier ... today announced that it has entered into an agreement to acquire the muscular dystrophy business of Edgewise Therapeutics Inc. (Nasdaq: EWTX) ... for up to $2.65 billion,…
Ambrosia Biosciences raised $100 million in its Series B funding round, led by Blue Owl, Redmile Group, and Deep Track Capital.
OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced that it has entered into a…
urban-gro shares jumped 182% on Monday after the company announced that its merger with Sri Lanka's Innovative Production Group, including its portfolio of T20 league commercial rights,…
Urban-gro, Inc. has finalized its merger with Flash Sports and Media, Inc., a U.S.-based company in the sports and media sector.
Enveda raised USD 150m after strong clinical validation of its AI-powered drug discovery platform.
Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced underwritten registered…
Workday, Inc. (NASDAQ: WDAY), the enterprise AI platform for managing people, money, and agents, announced it has completed its acquisition of Sana, a leading AI company building the…
Amended Hercules Capital Credit Facility: This amended agreement provides access to capital at Viridian’s discretion upon achievement of certain milestones, extends Viridian’s…
TLS Sound Labs has acquired Westone Laboratories, marking what the company is calling a new chapter rooted in the company’s original values of quality, service, and care.
CFS Technologies, a portfolio company of Union Park Capital, announced the acquisition of Meritech Systems, a Colorado-based manufacturer of fully automated hygiene and sanitation systems.
Workday, Inc. (NASDAQ: WDAY) has entered into a definitive agreement to acquire Sana, the Swedish artificial intelligence company known for AI-powered search, agents, and enterprise…
Ocugen said it executed a licensing agreement with Kwangdong for rights to OCU400, its modifier gene therapy for retinitis pigmentosa.
Enveda, a clinical-stage biotechnology company developing small-molecule drugs derived from nature’s chemistry, announced the close of a $150 million oversubscribed Series D financing,…
KROMATID, a leader in next-generation genomic structural analysis, today announced the successful close of its Series C funding round, raising a total of $8 million and surpassing its…
On June 22, 2025, Ocugen, Inc. and its subsidiary OrthoCellix, Inc. entered into a merger agreement with Carisma Therapeutics Inc. and its subsidiary, Azalea Merger Sub, Inc.
Zimmer and Biomet merged in 2015, with Biomet buying spine-tech developer Lanx before the deal and Zimmer Biomet later buying another spine company, LDR.
Caitlin Cronin has given her Hold rating due to a combination of factors surrounding Zimmer Biomet Holdings’ recent acquisition of Paragon 28.
Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn.
Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a leading muscle disease biopharmaceutical company, today announced the pricing of an underwritten offering of 9,935,419 shares of its common…
Myogen Inc. Denver 12/31 $14 Myogen raised another $14M in its Series D financing, bringing the total raised to $66.4M; investors included the Perseus-Soros BioPharmaceutical Fund LP,…
DSM Venturing, the corporate venturing unit of Royal DSM N.V., has made an equity investment in U.S.-based green chemistry company Segetis Inc.
Array's underwriters have an option to purchase up to 630,000 additional shares for overallotments. The value, $59M, is based on the Jan. 22 closing stock price.
Ribozyme Pharmaceuticals Inc. (RZYM) 7/7 1.8S $3.50 $6.3 $5.8 11 $39 HQ (placement agent)
Allos Therapeutics Inc. is raising $50 million in much‑needed financing, with proceeds to fund an ongoing Phase III trial of its lead drug candidate, Efaproxyn.
Invenux raised $6.7M in a Series A financing supported by Medallion Enterprises LLC and ATP Capital
Ampio previously raised $25 million in September 2013 in a registered direct offering.
Genicon raised $27M in the round; investors included Audax Ventures, CMEA Life Sciences; GIMV and Radius Ventures
Clovis Oncology Inc., of Boulder, Colo., said it plans an underwritten public offering of its common shares with a goal of raising approximately $175 million.
Few life sciences companies in Colorado publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 342 active companies.

AI-based platform to decipher the chemistry of nature and develop new medicines
Life sciences techUS$504.46m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene editing technology for research
GenomicsUS$502.33m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: CRISPR-based genome editing platforms and engineered microbes for synthetic isoprenoid production
CPC C12N9/22, C12N15/1082, C12N15/87Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of diagnostics assays for the detection of cancer
PulmonologyUS$200.16m across 21 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic assays and AI-driven biomarker analysis for cancer and infectious diseases
CPC G16B40/00, G01N33/57585, G01N33/5752Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of epigenetic therapies for the treatment of cancer.
OncologyUS$195.30m across 11 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of genes for pest and disease resistance in plants
GenomicsFocus: Genetically engineered crops for disease resistance, drought/salt tolerance, and hybrid seed production
CPC C12N15/8285, C12Q1/6895, C07K14/415Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for skeletal and cardiac muscle diseases
NeurologyUS$145.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical-grade wearable devices and data services for patient monitoring
Wearable technologyUS$140.05m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61B5/4833, A61B5/6833, A61B5/14517Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.
ImmunotherapyUS$131.81m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Yeast‑based cancer immunotherapies delivering tumor antigens such as brachyury.
CPC A61K36/064, A61K39/29, A61K39/292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule-based therapies for metabolic disorders
Metabolic diseasesUS$115.95m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a system for chronic rhinitis treatment via radiofrequency.
Ent disordersUS$110.17m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of Osteobiologic products
OrthopedicsUS$88.46m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Bioactive peptide-coated calcium‑phosphate coatings for orthopedic implants reducing inflammation
CPC A61L27/3608, A61L27/58, A61K35/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Early-stage drug delivery company developing Intracerebroventricular (ICV) delivery methods for Valproate for the treatment of neurological diseases such as epilepsy.
NeurologyUS$85.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drug delivery devices to treat cancers
OncologyUS$83.37m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted turbulent-flow catheter drug delivery and TLR9‑based immunotherapy for cancer
CPC C12N15/117, A61B17/12022, C07K16/2827Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of synthetic biology platform to develop small-molecule therapeutics
GenomicsUS$78.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of needle-free injection technology
Drug deliveryUS$59.40m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Jet injection devices for needle‑free drug delivery and precise dose control
CPC A61M5/30, A61M5/315, B65B3/003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of microRNA-based therapeutic solutions for treating multiple diseases
Gene therapyUS$55.61m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical devices for treating atrial fibrillation
Cardiac and vascular disordersUS$53.50m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of drug discovery platform for the treatment of cancer
Life sciences techUS$49.48m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene-editing technology
Life sciences platforms and toolsUS$48.27m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced nucleic‑acid library prep and engineered polymerases for next‑gen sequencing
CPC C12Q1/6834, C12N9/1276, G01N33/5758Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of thermostable vaccines
Life sciences techUS$46.68m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Stabilizing dried nucleic acid formulations and advanced CVD/ALD equipment for coating quality control
CPC C23C16/45544, A61K39/385, G01N33/15Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Minimally invasive surgical solution for specimen removal, improving patient outcomes
Surgical instrumentsUS$40.64m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Large‑volume tissue resection/removal devices, specimen containment, and electrosurgical RF cutting systems.
CPC A61B18/148, A61B18/1206, A61B17/00234Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Brand of nutrition drinks & supplements
Food & beverage productsUS$36.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of endovascular robots
Professional service robotsFocus: Robotic navigation and imaging systems for endovascular catheter procedures
CPC A61B34/20, G16H30/40, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of an artificial cervical disc for degenerative disc disease
OrthopedicsUS$30.41m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a device to prevent stroke during transcatheter aortic valve replacement heart procedures
NeurologyUS$26.77m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of Laser system device for acne treatment
DermatologyUS$25.28m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Photothermal acne therapy devices with integrated temperature sensing and closed-loop dosimetry control
CPC A61B18/203, G01J5/90, A61B18/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing influenza vaccines for seasonal and pandemic influenza
Infectious diseasesUS$22.82m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for auto-immune diseases
ImmunologyUS$22.21m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a medical device for un-sedated pediatric endoscopy
PediatricsUS$20.75m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced flexible endoscopic systems with precise fluid, electrical, and steering control
CPC A61M3/0283, A61B1/233, A61B1/00096Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovative dosing solutions to eliminate medication errors and improve patient safety
Hospital equipmentUS$19.73m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunomodulatory therapeutics for diabetes treatments
ImmunologyUS$17.85m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of airway management system for ventilated patients
PulmonologyUS$16.79m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of molecular and genetic tests for detection of disease-causing mutations
GenomicsUS$15.41m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Chromosome stability and genotoxicity analysis using advanced spectral karyotyping methods
CPC C12Q1/6841, C12Q1/6827, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Ultrasound device for micron resolution imaging of the anterior chamber
OphthalmologyUS$15.21m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of nutritional supplements based on the questionnaire
Nutraceuticals techUS$15.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Protein and antibody therapeutics discovery from concept to clinical candidate
Wound careUS$14.70m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medicines for patients with serious and rare diseases
ImmunologyUS$14.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of cancer
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a wearable sleep inducer for individuals
Fitness & wellness techUS$13.82m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing next-generation AEDs to improve survival rates from cardiac arrest
Cardiac and vascular disordersUS$13.61m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced AED devices integrating synchronized cardioversion, drug delivery, and adaptive power management
CPC A61N1/3904, A61N1/39044, A61N1/3975Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of prophylactic therapy for MDR-surgical site infections
Infectious diseasesUS$12.97m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/327, A01N59/00, A61F2/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing innovative nerve repair solutions for physicians and patients
NeurologyUS$12.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of wearable technology for people with foot ulcers and edema
Wound careUS$11.68m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of needle-free nasal spray
Life sciences platforms and toolsUS$11.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Dental intranasal anesthetic formulations and software for managing sales campaigns
CPC A61K31/245, A61K31/4164, A61K9/0043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing respiratory muscle stimulator technology to liberate patients from mechanical ventilation
Wearable technologyUS$11.31m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of tools and instruments for research
Life sciences platforms and toolsUS$11.21m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of progesterone based fertility test kits
Women healthEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Point-of-care software for malnutrition assessment and improved patient care
OrthopedicsUS$9.33m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Non‑invasive measurement of muscle metabolism and architecture for fitness/rehab monitoring
CPC A61B8/0858, A61B5/4519, A61B8/5223Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Cloud-based research data management tool for scientists
Life sciences techUS$8.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Colorado on RadarDiscover top life sciences companies in Colorado spanning research tools, diagnostics, and therapeutics. Explore life sciences startups in Colorado and companies building medical technologies.
Companies providing scientific tools, instruments, and platforms for research.

AI-based platform to decipher the chemistry of nature and develop new medicines
Life sciences tech
Developer of gene editing technology for research
GenomicsProvider of drug discovery platform for the treatment of cancer
Life sciences tech
Developer of thermostable vaccines
Life sciences tech
Developer of needle-free nasal spray
Life sciences platforms and toolsLife sciences companies developing therapies for cancer and other diseases.

Developer of diagnostics assays for the detection of cancer
Pulmonology
Developer of epigenetic therapies for the treatment of cancer.
Oncology
Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.
Immunotherapy
Developer of drug delivery devices to treat cancers
Oncology
Developer of therapeutics for cancer treatment
OncologyBusinesses using genetic, molecular, and diagnostic technologies for health research.

Developer of gene editing technology for research
Genomics
Developer of genes for pest and disease resistance in plants
Genomics
Provider of synthetic biology platform to develop small-molecule therapeutics
Genomics
Developer of microRNA-based therapeutic solutions for treating multiple diseases
Gene therapyProvider of drug discovery platform for the treatment of cancer
Life sciences techDevelopers of orthopedic, surgical, and patient-care medical devices.

Developer of a system for chronic rhinitis treatment via radiofrequency.
Ent disorders
Developer of Osteobiologic products
Orthopedics
Developer of medical devices for treating atrial fibrillation
Cardiac and vascular disorders
Minimally invasive surgical solution for specimen removal, improving patient outcomes
Surgical instruments
Developer of an artificial cervical disc for degenerative disc disease
OrthopedicsRecently founded life sciences companies in Colorado.

Developer of small molecule-based therapies for metabolic disorders
Metabolic diseases
Developer of therapeutics for cancer treatment
Oncology
A biotechnology company focused on advancing drug discovery through a chemistry-first platform
Life sciences tech
Developer of medical devices to decrease maternal mortality and morbidity during childbirth
Women health
Developer of AI-powered surgical guidance systems. The systems analyze live video feeds during minimally invasive surgery, overlaying crucial information onto the surgeon's monitor. This real-time visual guidance assists with intricate dissections and cancerous tissue identification. The system is designed for ease of use, requiring no additional training for surgeons. It leverages licensed intellectual property for its cancerous tissue recognition engine, providing a "Gross Exam in the OR" capability.
Surgical instrumentsLife sciences employers in Colorado with hiring activity.

Developer of diagnostics assays for the detection of cancer
Pulmonology
Developer of epigenetic therapies for the treatment of cancer.
Oncology
Developer of therapeutics for skeletal and cardiac muscle diseases
Neurology
Developer of medical-grade wearable devices and data services for patient monitoring
Wearable technology
Developer of Osteobiologic products
OrthopedicsListed life sciences companies based in Colorado.

Developer of diagnostics assays for the detection of cancer
Pulmonology
Developer of epigenetic therapies for the treatment of cancer.
Oncology
Developer of genes for pest and disease resistance in plants
Genomics
Developer of therapeutics for skeletal and cardiac muscle diseases
Neurology
Developing Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.
ImmunotherapyThe most-installed Android apps published by life sciences companies headquartered in Colorado — 65K installs between them. 6 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Colorado compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 497 life sciences companies in Colorado among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of Colorado maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
116 life sciences companies in Colorado have recorded equity funding, US$3.61bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
Life sciences techAI-based platform to decipher the chemistry of nature and develop new medicines
GenomicsDeveloper of gene editing technology for research
PulmonologyDeveloper of diagnostics assays for the detection of cancer
OncologyDeveloper of epigenetic therapies for the treatment of cancer.
GenomicsDeveloper of genes for pest and disease resistance in plants
NeurologyDeveloper of therapeutics for skeletal and cardiac muscle diseases
Wearable technologyDeveloper of medical-grade wearable devices and data services for patient monitoring
ImmunotherapyDeveloping Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.
Metabolic diseasesDeveloper of small molecule-based therapies for metabolic disorders
Ent disordersDeveloper of a system for chronic rhinitis treatment via radiofrequency.
OrthopedicsDeveloper of Osteobiologic products
NeurologyEarly-stage drug delivery company developing Intracerebroventricular (ICV) delivery methods for Valproate for the treatment of neurological diseases such as epilepsy.
OncologyDeveloper of drug delivery devices to treat cancers
GenomicsProvider of synthetic biology platform to develop small-molecule therapeutics
OncologyDeveloper of therapeutics for cancer treatment
Drug deliveryProvider of needle-free injection technology
US$504.46m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$502.33m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: CRISPR-based genome editing platforms and engineered microbes for synthetic isoprenoid production
CPC C12N9/22, C12N15/1082, C12N15/87Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$200.16m across 21 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic assays and AI-driven biomarker analysis for cancer and infectious diseases
CPC G16B40/00, G01N33/57585, G01N33/5752Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$195.30m across 11 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Genetically engineered crops for disease resistance, drought/salt tolerance, and hybrid seed production
CPC C12N15/8285, C12Q1/6895, C07K14/415Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$145.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$140.05m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61B5/4833, A61B5/6833, A61B5/14517Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$131.81m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Yeast‑based cancer immunotherapies delivering tumor antigens such as brachyury.
CPC A61K36/064, A61K39/29, A61K39/292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.95m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$110.17m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$88.46m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Bioactive peptide-coated calcium‑phosphate coatings for orthopedic implants reducing inflammation
CPC A61L27/3608, A61L27/58, A61K35/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$85.80m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$83.37m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted turbulent-flow catheter drug delivery and TLR9‑based immunotherapy for cancer
CPC C12N15/117, A61B17/12022, C07K16/2827Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$78.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$59.40m across 11 disclosed equity rounds
Darker bars = larger roundsFocus: Jet injection devices for needle‑free drug delivery and precise dose control
CPC A61M5/30, A61M5/315, B65B3/003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Colorado. 231 of 342 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences techDeveloper of thermostable vaccines
GenomicsProvider of next generation genome sequencing, bioinformatics, and data management service provider
Nutraceuticals techProvider of nutritional supplements based on the questionnaire
ImmunologyDeveloper of therapeutic solutions for treating common inflammatory conditions
Sports techNutrition for athletes, providing hydration, fuel, and recovery products
NeurologyDeveloping innovative nerve repair solutions for physicians and patients
Professional service robotsProvider of robotic surgery solution for the treatment of spinal disorders
GenomicsDesign and search tool to find the best flow cytometry products for the panel
Life sciences platforms and toolsLife science tools and critical quality control solutions provider
Wearable technologyDeveloping respiratory muscle stimulator technology to liberate patients from mechanical ventilation
Life sciences platforms and toolsBioLoomics is a preclinical stage biotechnology company that develops drug discovery tools and protein drugs.
Founders
Details not available
PulmonologyBreath alcohol and drug testing solutions for safety and compliance
US$46.68m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Stabilizing dried nucleic acid formulations and advanced CVD/ALD equipment for coating quality control
CPC C23C16/45544, A61K39/385, G01N33/15Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.66m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.31m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Automated cell sorting/extraction platforms and biosensor-based assay screening technologies.
CPC C12M47/04, G01N33/542Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Point‑of‑care chemical/biological analysis and surface decontamination technologies
CPC G01N33/0008, G01N21/35, A61L2/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Colorado with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
NeurologyProvider of seizure diagnosis platform


GenomicsDeveloper of gene editing technology for research
Women healthDeveloper of progesterone based fertility test kits
Surgical instrumentsMinimally invasive surgical solution for specimen removal, improving patient outcomes
Manufacturer of dietary supplements to manage body immunity power & other health related issues
PulmonologyDeveloper of airway management system for ventilated patients
Life sciences techCloud-based research data management tool for scientists
Provider of drug discovery platform for the treatment of cancer
GenomicsDeveloper of cancer diagnostics and companion diagnostics for drugs in development
Nutraceuticals techMicrobiome research products and services for advancing scientific discovery
Infectious diseasesRevolutionizing therapeutics with targeted live biotherapeutic delivery platform for advanced solutions
Fitness & wellness techActivity trackers for children
US$175k across 2 disclosed equity rounds
Darker bars = larger rounds

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$502.33m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: CRISPR-based genome editing platforms and engineered microbes for synthetic isoprenoid production
CPC C12N9/22, C12N15/1082, C12N15/87Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$40.64m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Large‑volume tissue resection/removal devices, specimen containment, and electrosurgical RF cutting systems.
CPC A61B18/148, A61B18/1206, A61B17/00234Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$16.79m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$49.48m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microsatellite genotyping and sample classification tools for genomic analysis
CPC G16B40/20, G06N20/20, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.37m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Probiotic therapeutic formulations and microbiome delivery devices for health applications.
CPC A61P1/00, A61K35/747Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Bacterial vector platforms for intracellular delivery of antibodies, mRNA, and therapeutic proteins
CPC C12N15/70, C12N15/111, C12N15/907Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Colorado founded in the last four years, newest first.
OrthopedicsDeveloper of therapies focused on restoring joints to healthy conditions
Founders
Details not available
Nutraceuticals techProvider of electrolyte drink mixes formulated for women's hormone health
Provider of gummy supplements designed to support male vitality and performance
Founders
Details not available
Life sciences techDeveloper of an AI platform for verifiable diagnostic manufacturing processes
Founders
Details not available
Metabolic diseasesDeveloper of small molecule-based therapies for metabolic disorders
Life sciences techA biotechnology company focused on advancing drug discovery through a chemistry-first platform
Life sciences platforms and toolsManufacturer of 3D bioprinted tissue implants for personalized regenerative medicine
Manufacturer of spinal surgery devices, technologies, and biologic solutions
Founders
Details not available
Online retailer of dietary supplements formulated for nerve health support
Founders
Details not available
Life sciences techDeveloper of research tools to manage the psychedelic drugs into healthcare settings
OrthopedicsManufacturer of implants and instrumentation for spinal stabilization and fusion
OncologyDeveloper of small-molecule therapies for oncology indications
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.95m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Protein crystal engineering for therapeutic proteins and industrial enzymes
CPC C12Q1/6809, C12Q1/6848, C12Q1/6876Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
PulmonologyDeveloper of diagnostics assays for the detection of cancer
Infectious diseasesDeveloper of therapeutic solutions to treat various eye disorders
OncologyDeveloper of drug delivery devices to treat cancers
OncologyDeveloping transformative therapies for rare diseases, focusing on hyperinsulinism (HI)
Life sciences platforms and toolsLife science tools and critical quality control solutions provider
ImmunologyDeveloper of medicines for patients with serious and rare diseases
Founders
Details not available
Life sciences techDeveloper of an AI-enabled drug discovery platform to treat fibrosis or neurodegenerative disease
OncologyDeveloper of epigenetic therapies for the treatment of cancer.
NeurologyDeveloper of therapeutics for skeletal and cardiac muscle diseases
OncologyDeveloper of drugs for solid tumours and blood cancers
ImmunotherapyDeveloping Tarmogen (vaccine) product candidates to treat cancer and infectious diseases.
Cannabis equipmentTurnkey design-build solutions for controlled environment agriculture and retail markets
US$200.16m across 21 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic assays and AI-driven biomarker analysis for cancer and infectious diseases
CPC G16B40/00, G01N33/57585, G01N33/5752Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K31/498, A61K48/0066, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$83.37m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted turbulent-flow catheter drug delivery and TLR9‑based immunotherapy for cancer
CPC C12N15/117, A61B17/12022, C07K16/2827Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Therapeutic antibodies targeting insulin receptor and plasma kallikrein inhibitors for oncology/metabolic diseases
CPC C07D231/14, A61K9/4866, A61K9/5052Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$195.30m across 11 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$145.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$131.81m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Yeast‑based cancer immunotherapies delivering tumor antigens such as brachyury.
CPC A61K36/064, A61K39/29, A61K39/292Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Colorado. Open a company to see what it sells, who runs it and how far it has come.
50 life sciences companies in Colorado work in life sciences platforms and tools. Shown: the best-documented.
GenomicsDeveloper of gene editing technology for research
Life sciences platforms and toolsDeveloper of gene-editing technology
GenomicsProvider of molecular and genetic tests for detection of disease-causing mutations
Life sciences platforms and toolsProvider of tools and instruments for research
GenomicsDesign and search tool to find the best flow cytometry products for the panel
Nutraceuticals techMicrobiome research products and services for advancing scientific discovery
Life sciences platforms and toolsDevelops technology to eliminate refrigeration for vaccines and protein therapeutics
Disease self managementDeveloper of oxygen delivery technology
Life sciences platforms and toolsDeveloper of flowers engineered to change color through biotechnology methods
Life sciences platforms and toolsDeveloping biopharmaceutical alternative therapies for menopausal vasomotor symptoms
Life sciences platforms and toolsDeveloper of needle-free nasal spray
Life sciences platforms and toolsDeveloper of tissue regeneration technology for ulcers and wound management
US$502.33m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: CRISPR-based genome editing platforms and engineered microbes for synthetic isoprenoid production
CPC C12N9/22, C12N15/1082, C12N15/87Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.27m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced nucleic‑acid library prep and engineered polymerases for next‑gen sequencing
CPC C12Q1/6834, C12N9/1276, G01N33/5758Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.41m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Chromosome stability and genotoxicity analysis using advanced spectral karyotyping methods
CPC C12Q1/6841, C12Q1/6827, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.21m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.66m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.37m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Probiotic therapeutic formulations and microbiome delivery devices for health applications.
CPC A61P1/00, A61K35/747Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$750k across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Oxygen delivery and gas‑control technologies for medical, wound care, and consumer products
CPC A61K33/00, A61K9/0014, A61K31/658Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.18m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Pharmaceutical compositions treating menopause and hormonal variation symptoms, including G‑CSF formulations.
CPC A61K38/193Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Dental intranasal anesthetic formulations and software for managing sales campaigns
CPC A61K31/245, A61K31/4164, A61K9/0043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
44 life sciences companies in Colorado work in nutraceuticals tech. Shown: the best-documented.
Nutraceuticals techProvider of nutritional supplements based on the questionnaire
Food & beverage productsBrand of nutrition drinks & supplements
Sports techBrand of energy drink powder
Founders
Details not available
Manufacturer of dietary supplements to manage body immunity power & other health related issues
Nutraceuticals techMicrobiome research products and services for advancing scientific discovery
Nutraceuticals techPatented, timed-release delivery system innovator for nutritional supplements and pharmaceuticals
Nutraceuticals techManufacturer of athlete-focused, science-backed body care products
Nutraceuticals techNatural sport drink and altitude sickness remedy for mountain travelers
Nutraceuticals techPure Cultures is an artisan facility providing custom probiotic strains for clients nationwide.
Founders
Details not available
Nutraceuticals techProvider of dietary supplements for multiple health conditions
Sports techNutrition for athletes, providing hydration, fuel, and recovery products
Nutraceuticals techOrganic sports nutrition for sustained energy, performance, and recovery
US$15.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.21m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.37m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Probiotic therapeutic formulations and microbiome delivery devices for health applications.
CPC A61P1/00, A61K35/747Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.75m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.45m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$400k across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K9/1075, A23L2/56, A61K9/1277Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
37 life sciences companies in Colorado work in oncology. Shown: the best-documented.
PulmonologyDeveloper of diagnostics assays for the detection of cancer
OncologyDeveloper of drug delivery devices to treat cancers
Gene therapyDeveloper of microRNA-based therapeutic solutions for treating multiple diseases
OncologyDeveloper of epigenetic therapies for the treatment of cancer.
Provider of drug discovery platform for the treatment of cancer
OncologyDeveloper of therapeutics for cancer treatment
GenomicsDeveloper of cancer diagnostics and companion diagnostics for drugs in development
OncologyDeveloper of metalloporphyrin based agents to treat inflammatory skin disease
OncologyInnovating diagnostic imaging for early and accurate breast cancer detection
Surgical instrumentsDeveloper of AI-powered surgical guidance systems. The systems analyze live video feeds during minimally invasive surgery, overlaying crucial information onto the surgeon's monitor. This real-time visual guidance assists with intricate dissections and cancerous tissue identification. The system is designed for ease of use, requiring no additional training for surgeons. It leverages licensed intellectual property for its cancerous tissue recognition engine, providing a "Gross Exam in the OR" capability.
Infectious diseasesRevolutionizing therapeutics with targeted live biotherapeutic delivery platform for advanced solutions
OncologyDeveloper of medical device for cancer diagnosis
US$200.16m across 21 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic assays and AI-driven biomarker analysis for cancer and infectious diseases
CPC G16B40/00, G01N33/57585, G01N33/5752Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$83.37m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted turbulent-flow catheter drug delivery and TLR9‑based immunotherapy for cancer
CPC C12N15/117, A61B17/12022, C07K16/2827Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$55.61m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$195.30m across 11 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$49.48m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microsatellite genotyping and sample classification tools for genomic analysis
CPC G16B40/20, G06N20/20, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Radioprotective and ischemia‑reperfusion injury drugs using metalloporphyrin and peptide formulations
CPC A61K31/555, A61P35/00, C07D487/22Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.77m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Bacterial vector platforms for intracellular delivery of antibodies, mRNA, and therapeutic proteins
CPC C12N15/70, C12N15/111, C12N15/907Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.14m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
36 life sciences companies in Colorado work in genomics. Shown: the best-documented.
GenomicsDeveloper of gene editing technology for research
Life sciences platforms and toolsDeveloper of gene-editing technology
Gene therapyDeveloper of microRNA-based therapeutic solutions for treating multiple diseases
GenomicsProvider of molecular and genetic tests for detection of disease-causing mutations
GenomicsProvider of synthetic biology platform to develop small-molecule therapeutics
GenomicsDesign and search tool to find the best flow cytometry products for the panel
Provider of drug discovery platform for the treatment of cancer
GenomicsDeveloper of cancer diagnostics and companion diagnostics for drugs in development
Nutraceuticals techMicrobiome research products and services for advancing scientific discovery
Life sciences platforms and toolsDeveloper of flowers engineered to change color through biotechnology methods
GenomicsDeveloper of genes for pest and disease resistance in plants
PulmonologyDeveloper of genetically-targeted therapeutic for pulmonary fibrosis
US$502.33m across 12 disclosed equity rounds
Darker bars = larger roundsFocus: CRISPR-based genome editing platforms and engineered microbes for synthetic isoprenoid production
CPC C12N9/22, C12N15/1082, C12N15/87Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.27m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced nucleic‑acid library prep and engineered polymerases for next‑gen sequencing
CPC C12Q1/6834, C12N9/1276, G01N33/5758Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$55.61m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.41m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Chromosome stability and genotoxicity analysis using advanced spectral karyotyping methods
CPC C12Q1/6841, C12Q1/6827, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$78.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.66m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$49.48m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microsatellite genotyping and sample classification tools for genomic analysis
CPC G16B40/20, G06N20/20, C12Q1/6883Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.37m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Probiotic therapeutic formulations and microbiome delivery devices for health applications.
CPC A61P1/00, A61K35/747Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Genetically engineered crops for disease resistance, drought/salt tolerance, and hybrid seed production
CPC C12N15/8285, C12Q1/6895, C07K14/415Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Early detection of pulmonary fibrosis via circulating biomarker assays
CPC G01N33/6893Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
185 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.